These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cold agglutinin syndrome in pediatric liver transplant recipients. Wong W, Merker JD, Nguyen C, Berquist W, Jeng M, Viele M, Glader B, Fontaine MJ. Pediatr Transplant; 2007 Dec; 11(8):931-6. PubMed ID: 17976131 [Abstract] [Full Text] [Related]
3. Lymphoproliferative disorder involving the cervix in a patient being treated with FK-506. Sunyecz JA, Price FV, Trucco G, Thomas R, Swerdlow SH. Gynecol Oncol; 1996 Aug; 62(2):301-3. PubMed ID: 8751565 [Abstract] [Full Text] [Related]
4. Autoimmune hemolytic anemia in solid organ transplantation-The role of immunosuppression. Kanellopoulou T. Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28621877 [Abstract] [Full Text] [Related]
5. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient. Kaczmarek I, Schmauss D, Sodian R, Beiras-Fernandez A, Oberhoffer M, Daebritz S, Schoenberg SO, Reichart B. J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523 [Abstract] [Full Text] [Related]
6. [Hemolytic anemia caused by graft-versus-host reaction in ABO-nonidentical renal transplants from blood group O donors]. Peces R, Díaz Corte C, Navascués RA. Nefrologia; 2001 Jan; 21(4):395-401. PubMed ID: 11816517 [Abstract] [Full Text] [Related]
7. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects. Asante-Korang A, Boyle GJ, Webber SA, Miller SA, Fricker FJ. J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602 [Abstract] [Full Text] [Related]
8. Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder. Barth RN, Nam AJ, Stanwix MG, Kukuruga D, Drachenberg CI, Bluebond-Langner R, Hui-Chou H, Shipley ST, Bartlett ST, Rodriguez ED. Transplantation; 2009 Dec 15; 88(11):1242-50. PubMed ID: 19996923 [Abstract] [Full Text] [Related]
9. Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. Mach-Pascual S, Samii K, Beris P. Am J Hematol; 1996 Aug 15; 52(4):310-2. PubMed ID: 8701950 [Abstract] [Full Text] [Related]
10. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME. Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581 [Abstract] [Full Text] [Related]
11. Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection. Ganschow R, Albani J, Grabhorn E, Richter A, Burdelski M. Pediatr Transplant; 2006 Mar 15; 10(2):220-4. PubMed ID: 16573611 [Abstract] [Full Text] [Related]
17. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J. Transplantation; 2003 Apr 15; 75(7):1020-5. PubMed ID: 12698091 [Abstract] [Full Text] [Related]
19. Autoimmune hemolytic anemia in patients with liver transplants for primary biliary cirrhosis: Three case reports and a review of the literature. Retana AK, Kaplan MM, Erban JK. Am J Gastroenterol; 2007 Jan 15; 102(1):197-200. PubMed ID: 17037996 [Abstract] [Full Text] [Related]
20. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. Trede NS, Warwick AB, Rosoff PM, Rohrer R, Bierer BE, Guinan E. Bone Marrow Transplant; 1997 Aug 15; 20(3):257-60. PubMed ID: 9257897 [Abstract] [Full Text] [Related] Page: [Next] [New Search]